Coronavirus and epilepsy

Written in association with: Dr Dora Lozsadi
Published:
Edited by: Robert Smith

Approximately 600,000 people in the UK have epilepsy. As cases of COVID-19 rise across the country, many of you with epilepsy may be wondering how coronavirus may affect you.

We spoke with a leading London neurologist, Dr Dora Lozsadi, to find out some of the answers to the most frequently asked questions.

 

Epilepsy and coronavirus

Does epilepsy affect the immune system? Are epileptics more at risk of symptoms?

Epilepsy is a disease caused by overactive brain networks. This condition does not affect the immune system. However, the causes of epilepsy are multiple. Those suffering from seizures will know whether this is caused by a stroke, meningioma or past head injury. These conditions will not affect the body’s defences. However, if there is associated breathing problems, a swallowing problem, or additional risk from age, this does change. 

 

There are other neurological problems causing epilepsy, such as a brain tumour or vasculitis (autoimmune inflammation of blood vessels), which are treated with immunosuppressive drugs. These patients may be at increased risk, and should contact specialists prescribing their medication for further advice. Some epilepsy patients are prescribed ACTH, steroids or everolimus, and these medications do affect the immune system. Your specialist will advise you if any action is needed.
 

Those who are vulnerable should have been contacted by their GP. If you feel you may be considered vulnerable, you may register on the gov.uk website.

 

Can the coronavirus trigger seizures?

No. Coronavirus causes infection of lung tissue (interstitial pneumonia), leading to breathing problems. Seizures may be more likely if the individual’s temperature is high. Most people with epilepsy will know their risk, i.e. may have suffered seizures in the past with other febrile illnesses. With time we expect to know more, as some infected with COVID-19 lose their sense of smell. Some treatments offered for coronavirus may interact with medication taken for epilepsy. Doctors are aware of this and can check with their pharmacist or on the ABN website.

 

What medication should epileptics take or avoid to treat symptoms?

Advice is similar to that offered to the general public. Stay at home to prevent infection, or if infected but well, avoid spreading the virus. If symptomatic (unwell) consult NHS 111 online, or your GP for further advice. Keep taking prescribed medication as recommended, and wash your hands.

 

Is it necessary to get extra epilepsy medicine in case going outside or to appointments isn’t possible?

GPs and community pharmacists are doing their utmost to ensure medication reaches people. If your stocks are low (10 days or less), please contact them over the phone. Should that fail, a local pharmacy will offer emergency supply for a couple of days. Your epilepsy nurse or specialist may also be able to help if all of the above fails. Ensure you have regular supplies, a reserve for a week (at least) without stockpiling.

 

Should epilepsy patients on specific diets, like the ketogenic diet, stop if they show symptoms or become ill?

There is no data to suggest a ketogenic diet puts people at risk of coronavirus infection. Restriction on travel and NHS services, however, may make monitoring a challenge. Those prescribed with a ketogenic diet should receive advice from their specialist. Some conditions (e.g. Glut 1 deficiency) require this diet as treatment of the underlying condition as well as epilepsy.
 

You can find regularly updated information about COVID-19 and coronavirus here.

For more guidance or health advice in relation to neurology, you can book a consultation with Dr Dora Lozsadi via her Top Doctors profile.

By Dr Dora Lozsadi
Neurology

Dr Dora Lozsadi is a an accomplished neurologist based at the Parkside Hospital in Wimbledon, London. She specialises in epilepsy, the management of epilepsy and the assessment of transient loss of consciousness. Currently, she is dedicated to grant-awarded research for Epilepsy Research UK on the study of brain activity using electrodes placed in the nose.

Dr Lozsadi gained her specialist training at the Walton Centre for Neurology and Neurosurgery, Liverpool and the National Hospital for Neurology and Neurosurgery (UCL), London. Prior to this, Dr Lozsadi was awarded her DPhil degree at the University of Oxford. She is currently an honorary senior lecturer for St George's, University of London.

At the core of Dr Lozsadi's approach is displacing the stigma surrounding neurological conditions and giving every patient treatment and care without prejudice. She has been a consultant neurologist for over ten years.

View Profile

Overall assessment of their patients


  • Related procedures
  • Botulinum toxin (Botox™)
    Neuropsychology
    Sleep disorders
    Learning disabilities
    Tinnitus
    Obstructive sleep apnea
    Neurological treatments
    Chronic headache
    Neuropathic pain
    Epilepsy
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.